All Stories

  1. Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma

    Article • Liver Cancer, May 2023, Karger Publishers

    Yi-Hsiang Huang

  2. Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice

    Article • BioMed Research International, June 2019, Hindawi Publishing Corporation

    Shiang-Fen Huang, Yi-Hsiang Huang

  3. Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents

    Article • Expert Review of Anti-infective Therapy, March 2019, Taylor & Francis

    Professor Lai Wei, Yi-Hsiang Huang

  4. Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan

    Article • Alimentary Pharmacology & Therapeutics, October 2018, Wiley

    Professor Tsai-Yuan Hsieh, Dr Chen-Hua Liu, Yi-Hsiang Huang

  5. Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg-positive cancer patients undergoing chemotherapy

    Article • Journal of Viral Hepatitis, September 2018, Wiley

    Dr Chien-Wei Su, Yi-Hsiang Huang

  6. Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system

    Article • Liver International, April 2018, Wiley

    Yi-Hsiang Huang

  7. Is antibody to surface antigen associated with hepatitis B reactivation in patients with resolved hepatitis B?

    Article • Hepatology, August 2017, Wiley

    Yi-Hsiang Huang

  8. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma

    Article • Liver International, August 2017, Wiley

    Dr Chien-Wei Su, Yi-Hsiang Huang

  9. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era

    Article • Journal of Gastroenterology and Hepatology, March 2017, Wiley

    Yi-Hsiang Huang

  10. Risk of Reverse Seroconversion of Hepatitis B Virus Surface Antigen in Rituximab-Treated Non-Hodgkin Lymphoma Patients

    Article • Medicine, August 2015, Wolters Kluwer Health

    Yi-Hsiang Huang

  11. Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B

    Article • Medicine, August 2015, Wolters Kluwer Health

    Yi-Hsiang Huang

  12. Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice

    Article • Medicine, April 2015, Wolters Kluwer Health

    Dr Chien-Wei Su, Yi-Hsiang Huang